Adamis Pharmaceuticals Corporation Gains 26.96%
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) soared at $0.73, representing a gain of 27%. On Fri, Jan 07, 2022, ADMP:NASDAQ hit a New 2-Week Intraday Low of $0.56. The stock got featured on our News Catalysts scanner on Mon, Jan 10, 2022 at 07:39 AM in the 'BIOTECH' category. From Mon, Dec 27, 2021, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Mon, Oct 18, 2021 at $1.48 with a volume of 151M+, and its share price has been moving sideways in recent weeks.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Zynga Inc. (ZNGA:NASDAQ), 40.67%
- MOLN (MOLN:NASDAQ), 30.46%
- RXST (RXST:NASDAQ), 28.21%
- BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ), 27.85%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 27.55%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 26.96%
- APR (APR:NASDAQ), 26.11%
- Pluristem Therapeutics Inc. (PSTI:NASDAQ), 24.49%
- OLK (OLK:NASDAQ), 23.8%
- BFRI (BFRI:NASDAQ), 22.03%